Needham Maintains Buy on RxSight, Lowers Price Target to $7
Benzinga Newsdesk 19 hours ago
Analyst RatingsNewsPrice Target
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $11 to $7.
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $11 to $7.